Cargando…
Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma
Epidemiological studies support a link between cumulative sun exposure and cutaneous squamous cell carcinoma (SCC) development. However, the presumed effects of extended ultraviolet light B (UVB) exposure on tumorigenesis in the sexes have not been formally investigated. We examined differences in u...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826430/ https://www.ncbi.nlm.nih.gov/pubmed/24286011 http://dx.doi.org/10.1155/2013/246848 |
_version_ | 1782290909103128576 |
---|---|
author | Burns, Erin M. Tober, Kathleen L. Riggenbach, Judith A. Kusewitt, Donna F. Young, Gregory S. Oberyszyn, Tatiana M. |
author_facet | Burns, Erin M. Tober, Kathleen L. Riggenbach, Judith A. Kusewitt, Donna F. Young, Gregory S. Oberyszyn, Tatiana M. |
author_sort | Burns, Erin M. |
collection | PubMed |
description | Epidemiological studies support a link between cumulative sun exposure and cutaneous squamous cell carcinoma (SCC) development. However, the presumed effects of extended ultraviolet light B (UVB) exposure on tumorigenesis in the sexes have not been formally investigated. We examined differences in ultimate tumorigenesis at 25 weeks in mice exposed to UVB for either 10 or 25 weeks. Additionally, we investigated the effect of continued UVB exposure on the efficacy of topical treatment with anti-inflammatory (diclofenac) or antioxidant (C E Ferulic or vitamin E) compounds on modulating tumorigenesis. Vehicle-treated mice in the 25-week UVB exposure model exhibited an increased tumor burden and a higher percentage of malignant tumors compared to mice in the 10-week exposure model, which correlated with increases in total and mutant p53-positive epidermal cells. Only topical diclofenac decreased tumor number and burden in both sexes regardless of UVB exposure length. These data support the commonly assumed but not previously demonstrated fact that increased cumulative UVB exposure increases the risk of UVB-induced SCC development and can also affect therapeutic efficacies. Our study suggests that cessation of UVB exposure by at-risk patients may decrease tumor development and that topical NSAIDs such as diclofenac may be chemopreventive. |
format | Online Article Text |
id | pubmed-3826430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-38264302013-11-27 Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma Burns, Erin M. Tober, Kathleen L. Riggenbach, Judith A. Kusewitt, Donna F. Young, Gregory S. Oberyszyn, Tatiana M. J Skin Cancer Research Article Epidemiological studies support a link between cumulative sun exposure and cutaneous squamous cell carcinoma (SCC) development. However, the presumed effects of extended ultraviolet light B (UVB) exposure on tumorigenesis in the sexes have not been formally investigated. We examined differences in ultimate tumorigenesis at 25 weeks in mice exposed to UVB for either 10 or 25 weeks. Additionally, we investigated the effect of continued UVB exposure on the efficacy of topical treatment with anti-inflammatory (diclofenac) or antioxidant (C E Ferulic or vitamin E) compounds on modulating tumorigenesis. Vehicle-treated mice in the 25-week UVB exposure model exhibited an increased tumor burden and a higher percentage of malignant tumors compared to mice in the 10-week exposure model, which correlated with increases in total and mutant p53-positive epidermal cells. Only topical diclofenac decreased tumor number and burden in both sexes regardless of UVB exposure length. These data support the commonly assumed but not previously demonstrated fact that increased cumulative UVB exposure increases the risk of UVB-induced SCC development and can also affect therapeutic efficacies. Our study suggests that cessation of UVB exposure by at-risk patients may decrease tumor development and that topical NSAIDs such as diclofenac may be chemopreventive. Hindawi Publishing Corporation 2013 2013-10-27 /pmc/articles/PMC3826430/ /pubmed/24286011 http://dx.doi.org/10.1155/2013/246848 Text en Copyright © 2013 Erin M. Burns et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Burns, Erin M. Tober, Kathleen L. Riggenbach, Judith A. Kusewitt, Donna F. Young, Gregory S. Oberyszyn, Tatiana M. Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma |
title | Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma |
title_full | Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma |
title_fullStr | Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma |
title_full_unstemmed | Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma |
title_short | Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma |
title_sort | extended uvb exposures alter tumorigenesis and treatment efficacy in a murine model of cutaneous squamous cell carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826430/ https://www.ncbi.nlm.nih.gov/pubmed/24286011 http://dx.doi.org/10.1155/2013/246848 |
work_keys_str_mv | AT burnserinm extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma AT toberkathleenl extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma AT riggenbachjuditha extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma AT kusewittdonnaf extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma AT younggregorys extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma AT oberyszyntatianam extendeduvbexposuresaltertumorigenesisandtreatmentefficacyinamurinemodelofcutaneoussquamouscellcarcinoma |